Trump’s 3,642 Stock Trades Spark Market Ethics Debate Now
New filings reveal a surge of political stock trading in Q1, prompting renewed calls for a ban on individual trades b...
Learn when bonds may outperform stocks for retirement, with practical timing cues and risk considerations.
24,889 articlesNew filings reveal a surge of political stock trading in Q1, prompting renewed calls for a ban on individual trades b...
This earnings season produced a mix of wins and misses. We break down what worked what didn't, with actionable tips y...
What could Palantir's stock do by the end of 2027? This article builds three forward-looking scenarios, weighs risks,...
Tech stocks staged a partial recovery on Monday as the Nasdaq rebounded, but higher oil prices and stubborn yields ke...
SpaceX stock rose again Monday after Elon Musk signaled a possible $1 trillion in annual revenue by 2030, fueling a b...
The eVTOL craze mixes hype with real engineering, regulatory hurdles, and capital burn. Here's why I wouldn't touch t...
Stocks climbed on Monday after weekend actions in the Middle East, extending a pattern investors have watched in seve...
A wide-open weight-loss drug market has investors buzzing about Viking Therapeutics. This article breaks down the bul...
As AI spending hits record levels, Chamath Palihapitiya argues the real test is whether buyers of AI can deliver dura...
A rare public reversal from Elon Musk shines a light on Anthropic as a leading AI player. For Amazon and Alphabet inv...
At New Delhi's AI Impact Summit, a staged gesture exposed rivalries among top AI leaders, triggering a rethink of AI ...
A major investment firm boosted its Dyne Therapeutics stake by nearly $4 million, highlighting renewed interest in DY...